Sign in
Molecular BiologyPlant and Cell Physiology
Peer-reviewed journal article

A Cys2/His2 zinc finger protein acts as a repressor of gibberellins biosynthesis by regulating SD1/OsGA20ox2 in rice (Oryza sativa L.)

Min DuaniD, Xiao-Juan Ke, Hongxia LaniD, Xi YuaniD, Peng HuangiD, Enshun Xu, Xiuying GaoiD, Ruqin Wang, Haijuan TangiD, Hongsheng ZhangiD, Ji HuangiD

Abstract

Gibberellins (GAs) play important roles in the regulation of plant growth and development. The green evolution gene SD1 encoding gibberellin 20-oxidase 2 (GA20ox2) has been widely used in modern rice breeding. However, the molecular mechanism of how SD1/OsGA20ox2 expression is regulated remains unclear. Here we report a Cys2/His2 zinc finger protein ZFP207 acting as a transcriptional repressor of OsGA20ox2. ZFP207 was mainly accumulated in young tissues and more specifically in culm nodes. ZFP207-overexpression (ZFP207OE) plants displayed semi-dwarfism phenotype and small grains by modulating cell length. RNA interference of ZFP207 caused higher plant and longer grains. The endogenous bioactive GA levels were significantly reduced in ZFP207OE plants and application of exogenous GA3 rescued the semi-dwarf phenotype. The in vivo and in vitro studies showed that ZFP207 repressed the expression of OsGA20ox2 via binding to its promoter region. Together, ZFP207 acts as a transcriptional repressor of gibberellins biosynthesis and it may play a critical role in plant growth and development through fine-tuning GA biosynthesis in rice.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers
Citations
30
FWCI
1.77
Field percentile
top 16%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISDong '21Leydon '25Griffiths '23Zhou '19Jaiswal '24Kubalová '25
65% semantic matchPlant Biology
S. Dong, D. Tarkowska, M. Sedaghatmehr+4 more·bioRxiv·Feb 17, 2021